The odds that working women will accept cervical cancer screening and HPV vaccination


  • Ezekiel Uba Nwose School of Community Health, Charles Sturt University, Orange NSW, Australia
  • Uchechukwuka Nnemdi Okwe Delta State secretariat Clinic, Asaba, Delta State, Nigeria
  • Helen Chime Department of Public & Community Health, Novena University, Ogume, Delta State, Nigeria



Cervical screening services, Odds ratio, Unwillingness to accept


Background: Factors influencing acceptance of cervical cancer services are being investigated, and widely reported to be quite low. However, there is dearth of research investigation on the odds of women’s acceptance of this gynaecological service. Objective of this study was to investigates the odds of unwilling to accept cervical cancer services.

Methods: The study was a questionnaire-based cross-sectional survey and fourth piece in a series of analysis. Details of data collection are as previously described. Odds ratio was determined using online calculator; and based on proportion of respondents who have accepted the cervical cancer service, willing to complete an incomplete process and encourage others to take up the procedure.

Results: The percentage of respondents who indicated no problem with HPV vaccination (55%) is higher than cervical screening (53%), but not statistically significantly different. On average, unwillingness to vaccinate later, complete their vaccinations or encourage their daughter are one-third of those who vaccinated. Those unwilling to take up cervical screening, encourage others to screen or overcome their fears are more than (161%) the subgroup who have been screened. Results show odds of unwillingness for both procedures are less than 1, but a little greater for cervical screening.

Conclusions: It has been articulated that the likelihood to take up cervical cancer services will be influenced by the beliefs. This report advances that observed low acceptance level does not translate to high likelihood of unwillingness to accept the gynaecological services. Belief and nature of work of women need to be concertedly investigated.


Kitchener HC, Castle PE, Cox JT. Achievements and limitations of cervical cytology screening. Vaccine. 2006;24:S63-S70.

Palacio-Mejia LS, Rangel-Gomez G, Hernandez-Avila M, Lazcano-Ponce E. Cervical cancer, a disease of poverty: mortality differences between urban and rural areas in Mexico. Salud Publica Mex. 2003;45 Suppl 3:S315-25.

Nwobodo H, Ba-Break M. Analysis of the determinants of low cervical cancer screening uptake among Nigerian women. J Public Health Afr. 2015;6(2):484.

Nnodu O, Erinosho L, Jamda M, Olaniyi O, Adelaiye R, Lawson L, et al. Knowledge and attitudes towards cervical cancer and human papillomavirus: a Nigerian pilot study. Afr J Reprod Health. 2010;14(1):95-108.

Akujobi CN, Ikechebelu JI, Onunkwo I, Onyiaorah IV. Knowledge, attitude and practice of screening for cervical cancer among female students of a tertiary institution in South Eastern Nigeria. Niger J Clin Pract. 2008;11(3):216-9.

Udigwe GO. Knowledge, attitude and practice of cervical cancer screening (pap smear) among female nurses in Nnewi, South Eastern Nigeria. Niger J Clin Pract. 2006;9(1):40-3.

Aboyeji PA, Ijaiya M-DA, Jimoh A-GA. Knowledge, attitude and practice of cervical cancer as screening procedure for cervical cancer in Ilorin, Nigeria. Trop J Obstet Gynaecol. 2004;21(2):114-7.

Makwe CC, Anorlu RI, Odeyemi KA. Human papillomavirus (HPV) infection and vaccines: knowledge, attitude and perception among female students at the University of Lagos, Lagos, Nigeria. J Epidemiol Glob Health. 2012;2(4):199-206.

Assoumou SZ, Mabika BM, Mbiguino AN, Mouallif M, Khattabi A, Ennaji MM. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women. BMC Woman’s Health. 2015;15:37.

Guimond ME, Salman K. Modesty matters: cultural sensitivity and cervical cancer prevention in muslim women in the United States. Nurs Womens Health. 2013;17(3):210-6.

Ayinde OA, Ogunbode OO, Adebayo OJ. Determinants of cervical cancer knowledge and its utilization of screening among a Nigerian female population. Trop J Obstet Gynaecol. 2005;22(1):21-4.

World Health Organization. Cancer, 2019. Available at: prevention/diagnosis-screening/cervical-cancer/en/.

MedCalc Software. Odds ratio calculator, 2018. Available at: odds_ratio.php.

Ganczak M, Owsianka B, Korzeń M. Factors that predict parental willingness to have their children vaccinated against HPV in a country with low HPV vaccination coverage. Int J Environ Res Public Health. 2018;15(4):645.

Ibekwe CM, Hoque ME, Ntuli-Ngcobo B. Perceived susceptibility of cervical cancer screening among women attending Mahalapye District Hospital, Botswana. Southern Afr J Epidemiol Infection. 2010;25(2):16-21.

Balogun F, Omotade O. She must have been sleeping around Contextual interpretations of cervical cancer and views regarding HPV vaccination for adolescents in selected communities in Ibadan, Nigeria. PLoS One. 2018;13(9):e0203950.

Vorsters A, Arbyn M, Baay M, Bosch X, de Sanjose S, Hanley S, et al. Overcoming barriers in HPV vaccination and screening programs. Papillomavirus Res. 2017;4:45-53.

Grandahl M, Paek SC, Grisurapong S, Sherer P, Tyden T, Lundberg P. Parents' knowledge, beliefs, and acceptance of the HPV vaccination in relation to their socio-demographics and religious beliefs: A cross-sectional study in Thailand. PLoS One. 2018;13(2):e0193054.

Santhanes D, Yong CP, Yap YY, Saw PS, Chaiyakunapruk N, Khan TM. Factors influencing intention to obtain the HPV vaccine in South East Asian and Western Pacific regions: A systematic review and meta-analysis. Sci Rep. 2018;8(1):3640.

Silas OA, Achenbach CJ, Murphy RL, Hou L, Sagay SA, Banwat E, et al. Cost effectiveness of human papilloma virus vaccination in low and middle income countries: a systematic review of literature. Expert Rev Vaccines. 2018;17(1):91-8.

Wong CKH, Liao Q, Guo VYW, Xin Y, Lam CLK. Cost-effectiveness analysis of vaccinations and decision makings on vaccination programmes in Hong Kong: A systematic review. Vaccine. 2017;35(24):3153-61.

Gervais F, Dunton K, Jiang Y, Largeron N. Systematic review of cost-effectiveness analyses for combinations of prevention strategies against human papillomavirus (HPV) infection: a general trend. BMC Public Health. 2017;17(1):283.

Cutts FT, Franceschi S, Goldie S, Castellsague X, de Sanjose S, Garnett G, et al. Human papillomavirus and HPV vaccines: a review. Bull World Health Organ. 2007;85(9):719-26.

Dixon D, Johnston M. Health behaviour change competency framework: NHS Health Scotland, 2010. Available at:

Johnston M, editor Using behaviour change theory and techniques in implementation research. The 4th Biennial Society for Implementation Research Collaboration conference; 2017; Seattle: SIRC 2017. Available at:




How to Cite

Nwose, E. U., Okwe, U. N., & Chime, H. (2019). The odds that working women will accept cervical cancer screening and HPV vaccination. International Journal of Research in Medical Sciences, 7(5), 1781–1786.



Original Research Articles